MCIM
QTTB icon

Meadow Creek Investment Management’s Q32 Bio QTTB Stock Holding History

Meadow Creek Investment Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$19K Buy
+57
New +$19.4K ﹤0.01% 1324

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Meadow Creek Investment Management's QTTB Position: Q3 2019 in Review

Meadow Creek Investment Management opened a new position in Q32 Bio (QTTB) in Q3 2019: 57 shares worth $19K. The stake represents ﹤0.01% of the portfolio and ranks #1324 among its holdings.

80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

  • Meadow Creek Investment Management held 57 shares of Q32 Bio worth $19K as of Q3 2019.
  • Q32 Bio was a new Meadow Creek Investment Management position in Q3 2019.
  • Q32 Bio made up ﹤0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #1324 holding.
  • 80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.